• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长抑素输注对4例恶性类癌综合征患者的影响。

Effects of somatostatin infusion in four patients with malignant carcinoid syndrome.

作者信息

Quatrini M, Basilisco G, Conte D, Bozzani A, Bardella M T, Bianchi P A

出版信息

Am J Gastroenterol. 1983 Mar;78(3):149-51.

PMID:6187212
Abstract

Somatostatin (4 micrograms/min, cyclic form) was infused for 24 h on six occasions in four patients with carcinoid ileal tumor and multiple liver metastases. During infusion, spontaneous flushes and/or diarrhea were markedly reduced with a return to the pretreatment pattern on the next day. Urinary 5-hydroxyindole acetic acid excretion and plasma gastrin were not significantly changed, whereas plasma insulin presented the expected decrease and rebound. These results confirm that carcinoid symptoms are somatostatin-sensitive but do not provide evidence that serotonin or gastrin play a major role in inducing these symptoms.

摘要

对4例患有类癌性回肠肿瘤并伴有多处肝转移的患者,分6次进行了24小时的生长抑素(4微克/分钟,环状形式)输注。输注期间,自发性潮红和/或腹泻明显减轻,次日恢复到治疗前的状态。尿5-羟吲哚乙酸排泄量和血浆胃泌素没有明显变化,而血浆胰岛素呈现出预期的下降和反弹。这些结果证实类癌症状对生长抑素敏感,但没有提供证据表明5-羟色胺或胃泌素在诱发这些症状中起主要作用。

相似文献

1
Effects of somatostatin infusion in four patients with malignant carcinoid syndrome.生长抑素输注对4例恶性类癌综合征患者的影响。
Am J Gastroenterol. 1983 Mar;78(3):149-51.
2
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.恶性类癌综合征的治疗。一种长效生长抑素类似物的评估。
N Engl J Med. 1986 Sep 11;315(11):663-6. doi: 10.1056/NEJM198609113151102.
3
[A prolonged-action somatostatin analog and carcinoid syndrome].一种长效生长抑素类似物与类癌综合征
Bull Acad Natl Med. 1989 May;173(5):643-50; discussion 650-1.
4
[Effects of the administration of somatostatin 14 in the carcinoid syndrome. Clinical and biological study of 2 cases].[生长抑素14治疗类癌综合征的效果。2例临床及生物学研究]
Gastroenterol Clin Biol. 1983 Dec;7(12):1016-22.
5
Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome.生长抑素输注对一名因恶性类癌综合征导致分泌性腹泻患者空肠水和电解质转运的影响。
Gastroenterology. 1980 Feb;78(2):346-9.
6
[A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].[一名类癌综合征患者对生长抑素类似物SMS 201-995产生良好反应]
Rev Esp Enferm Dig. 1991 Mar;79(3):215-7.
7
Primary carcinoid tumor of the bilateral testis associated with carcinoid syndrome.双侧睾丸原发性类癌瘤伴类癌综合征。
Int J Urol. 2004 Nov;11(11):1041-3. doi: 10.1111/j.1442-2042.2004.00925.x.
8
Treatment of the carcinoid syndrome with somatostatin, salmon calcitonin, or octreotide.用生长抑素、鲑鱼降钙素或奥曲肽治疗类癌综合征。
Clin Ther. 1992 Mar-Apr;14(2):178-84.
9
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.曲替瑞林乙酯,色氨酸羟化酶抑制剂,用于治疗类癌综合征。
J Clin Oncol. 2017 Jan;35(1):14-23. doi: 10.1200/JCO.2016.69.2780. Epub 2016 Oct 28.
10
The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.奥曲肽对类癌综合征患者基础和刺激状态下激素水平的影响。
J Clin Endocrinol Metab. 1989 Apr;68(4):796-800. doi: 10.1210/jcem-68-4-796.

引用本文的文献

1
Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel.
Dig Dis Sci. 1995 Jul;40(7):1464-73. doi: 10.1007/BF02285194.
2
Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue.皮下注射一种新的生长抑素类似物后对五肽胃泌素刺激的胃酸分泌的抑制作用。
Gut. 1986 Feb;27(2):141-6. doi: 10.1136/gut.27.2.141.
3
Gastroenteropancreatic endocrine tumors.胃肠胰内分泌肿瘤
Klin Wochenschr. 1985 May 15;63(10):433-59. doi: 10.1007/BF01731493.